Our mission
We are revolutionizing the field of early detection of diseases through the analyses of patient-derived extracellular vesicles (EVs).
We aim at a precise and early diagnosis ultimately leading to a better disease outcome, starting from blood withdrawal as input material, a minimally invasive procedure.
Our technology
We develop innovative clinical applications exploiting our proprietary high-performance technology to isolate and characterize high quality extracellular vesicles (EVs).
About us
AEVA is a biotech spin-off of the University of Trento (Italy), incubated at the Department of Cellular, Computational and Integrative Biology, where a new method of EVs isolation was discovered and optimized, opening up possibilities for a diagnosis at an unprecedented level of sensitivity and accuracy.